Retrobulbar injection of methylprednisolone in diffuse diabetic macular edema

Retina

Volumn 24, Issue 6, 2004, Pages 905-909

  Knudsen, Lars Loumann ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetic macular edema; Diabetic maculopathy; Diabetic retinopathy; Methylprednisolone

Indexed keywords

GLIPIZIDE; INSULIN; METFORMIN; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; MALE; POSTOPERATIVE PERIOD; RETINA MACULA EDEMA; VISUAL ACUITY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLIPIZIDE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; METFORMIN; METHYLPREDNISOLONE; MIDDLE AGED; ORBIT; VISUAL ACUITY;

EID: 10644290848     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200412000-00010     Document Type: Article

References (17)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: ET-DRS report no. 1. Arch Ophthalmol 1985;103:1796-1806.
2. Bek T, Møller F, Klausen B. Short term visual prognosis after retinal laser photocoagulation for diabetic maculopathy. Acta Ophthalmol Scand 2000;78:539-542.
3. Andersen C, Jensen FT. Differences in blood-tumour-barrier leakage of human intracranial tumours: quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment. Acta Neurochir 1998;140:919-924.
4. Kalmann R, Mourits MP. Diabetes mellitus: a risk factor in patients with Graves' orbitopathy. Br J Ophthalmol 1999;83:463-465.
5. DeBloch CE. Diabetes mellitus type 1 and associated organ-specific autoimmunity. Verh K Acad Geneeskd Belg 2000;62:285-328.
6. Perros P, Singh RK, Ludham CA, Frier BM. Prevalence of pernicious anaemia in patients with type 1 diabetes mellitus and autoimmune thyroid disease. Diabet Med 2000;17:749-751.
7. Papadopoulis KI, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease. Acta Endocrinol 1990;122:472-478.
8. Chung TW, et al. Reducing lipid peroxidation stress of erythrocyte membrane by alpha-tocophenol nicotinate plays an important role in improving blood rheological properties in type 2 diabetic patients with retinopathy. Diabet Med 1998;15:380-385.
9. Barouch FC, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 2000;41:1153-1158.
10. Nauck M, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309-315.
11. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
12. Bach M, Kommerell G. Determining visual acuity using European normal values: scientific principles and possibilities for automatic measurements. Klin Monatsbl Augenheilkd 1998;212:190-195.
13. Bach M. The Freiburg Vision Test. Automated determination of visual acuity. Ophthalmology 1995;92:174-178.
14. Knudsen LL. Visual acuity testing in diabetic subjects. Decimal progression chart versus European visual acuity standard. Graefes Arch Clin Exp Ophthalmol 2003;241:615-618.
15. Sander B, et al. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier in relation to metabolic control. Acta Ophthalmol (Copenh) 1994;74:553-559.
16. Sander B. Diabetisk makulaødem: Blod-nethindebarrierens permeabilitet og kapillær angiografi. Metodeudvikling og et klinisk Studie. PhD thesis. University of Copenhagen. 2000.
17. Ashton N. Studies on the retinal capillaries in relation to diabetes and other retinopathies. Br J Ophthalmol 1963;47:521-538.